- Home
- BOLD vs FMY Comparison
BOLD vs FMY Comparison
Compare BOLD & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- FMY
- Stock Information
- Founded
- BOLD 2018
- FMY 2005
- Country
- BOLD United States
- FMY United States
- Employees
- BOLD N/A
- FMY N/A
- Industry
- BOLD
- FMY Finance/Investors Services
- Sector
- BOLD
- FMY Finance
- Exchange
- BOLD Nasdaq
- FMY Nasdaq
- Market Cap
- BOLD 60.4M
- FMY 52.1M
- IPO Year
- BOLD 2024
- FMY N/A
- Fundamental
- Price
- BOLD $2.35
- FMY $11.97
- Analyst Decision
- BOLD Strong Buy
- FMY
- Analyst Count
- BOLD 3
- FMY 0
- Target Price
- BOLD $23.00
- FMY N/A
- AVG Volume (30 Days)
- BOLD 84.8K
- FMY 10.1K
- Earning Date
- BOLD 11-07-2024
- FMY 01-01-0001
- Dividend Yield
- BOLD N/A
- FMY 6.98%
- EPS Growth
- BOLD N/A
- FMY N/A
- EPS
- BOLD N/A
- FMY N/A
- Revenue
- BOLD N/A
- FMY N/A
- Revenue This Year
- BOLD N/A
- FMY N/A
- Revenue Next Year
- BOLD N/A
- FMY N/A
- P/E Ratio
- BOLD N/A
- FMY N/A
- Revenue Growth
- BOLD N/A
- FMY N/A
- 52 Week Low
- BOLD $2.33
- FMY $10.71
- 52 Week High
- BOLD $15.24
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- FMY 47.07
- Support Level
- BOLD N/A
- FMY $11.81
- Resistance Level
- BOLD N/A
- FMY $12.03
- Average True Range (ATR)
- BOLD 0.00
- FMY 0.12
- MACD
- BOLD 0.00
- FMY 0.00
- Stochastic Oscillator
- BOLD 0.00
- FMY 59.26
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities.